11-22274548-CTTTTT-CTTTTTT
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_213599.3(ANO5):c.2236-10dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0194 in 1,154,642 control chromosomes in the GnomAD database, including 16 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 10 hom., cov: 27)
Exomes 𝑓: 0.021 ( 6 hom. )
Consequence
ANO5
NM_213599.3 intron
NM_213599.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.693
Publications
3 publications found
Genes affected
ANO5 (HGNC:27337): (anoctamin 5) This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
ANO5 Gene-Disease associations (from GenCC):
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- gnathodiaphyseal dysplasiaInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive limb-girdle muscular dystrophy type 2LInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- Miyoshi muscular dystrophy 3Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 11-22274548-C-CT is Benign according to our data. Variant chr11-22274548-C-CT is described in ClinVar as [Benign]. Clinvar id is 195544.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0076 (1118/147054) while in subpopulation AFR AF = 0.0223 (901/40388). AF 95% confidence interval is 0.0211. There are 10 homozygotes in GnomAd4. There are 506 alleles in the male GnomAd4 subpopulation. Median coverage is 27. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00758 AC: 1114AN: 146982Hom.: 10 Cov.: 27 show subpopulations
GnomAD3 genomes
AF:
AC:
1114
AN:
146982
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0304 AC: 3497AN: 115060 AF XY: 0.0295 show subpopulations
GnomAD2 exomes
AF:
AC:
3497
AN:
115060
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0211 AC: 21236AN: 1007588Hom.: 6 Cov.: 0 AF XY: 0.0210 AC XY: 10468AN XY: 498356 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
21236
AN:
1007588
Hom.:
Cov.:
0
AF XY:
AC XY:
10468
AN XY:
498356
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1072
AN:
23556
American (AMR)
AF:
AC:
821
AN:
25008
Ashkenazi Jewish (ASJ)
AF:
AC:
480
AN:
16178
East Asian (EAS)
AF:
AC:
1138
AN:
23652
South Asian (SAS)
AF:
AC:
1792
AN:
56792
European-Finnish (FIN)
AF:
AC:
708
AN:
37442
Middle Eastern (MID)
AF:
AC:
135
AN:
4316
European-Non Finnish (NFE)
AF:
AC:
14121
AN:
779110
Other (OTH)
AF:
AC:
969
AN:
41534
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.260
Heterozygous variant carriers
0
3069
6138
9208
12277
15346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00760 AC: 1118AN: 147054Hom.: 10 Cov.: 27 AF XY: 0.00706 AC XY: 506AN XY: 71654 show subpopulations
GnomAD4 genome
AF:
AC:
1118
AN:
147054
Hom.:
Cov.:
27
AF XY:
AC XY:
506
AN XY:
71654
show subpopulations
African (AFR)
AF:
AC:
901
AN:
40388
American (AMR)
AF:
AC:
66
AN:
14658
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
3364
East Asian (EAS)
AF:
AC:
83
AN:
5050
South Asian (SAS)
AF:
AC:
2
AN:
4634
European-Finnish (FIN)
AF:
AC:
9
AN:
9520
Middle Eastern (MID)
AF:
AC:
3
AN:
286
European-Non Finnish (NFE)
AF:
AC:
38
AN:
66238
Other (OTH)
AF:
AC:
9
AN:
2014
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
52
104
157
209
261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Feb 10, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
Nov 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 03, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Miyoshi muscular dystrophy 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Gnathodiaphyseal dysplasia Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.